149 related articles for article (PubMed ID: 34897916)
1. PolyI:C attenuates transforming growth factor-β signaling to induce cytostasis of surrounding cells by secreted factors in triple-negative breast cancer.
Tamura Y; Tsutsumi S; Miyazono K; Koinuma D
Cancer Sci; 2022 Mar; 113(3):940-949. PubMed ID: 34897916
[TBL] [Abstract][Full Text] [Related]
2. Anti-pyroptotic function of TGF-β is suppressed by a synthetic dsRNA analogue in triple negative breast cancer cells.
Tamura Y; Morikawa M; Tanabe R; Miyazono K; Koinuma D
Mol Oncol; 2021 May; 15(5):1289-1307. PubMed ID: 33342034
[TBL] [Abstract][Full Text] [Related]
3. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
4. The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer.
Doherty MR; Parvani JG; Tamagno I; Junk DJ; Bryson BL; Cheon HJ; Stark GR; Jackson MW
Breast Cancer Res; 2019 Apr; 21(1):54. PubMed ID: 31036052
[TBL] [Abstract][Full Text] [Related]
5. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
6. Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer.
Wahdan-Alaswad R; Harrell JC; Fan Z; Edgerton SM; Liu B; Thor AD
Cell Cycle; 2016; 15(8):1046-59. PubMed ID: 26919310
[TBL] [Abstract][Full Text] [Related]
7. TGF-β/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters.
Webb BM; Bryson BL; Williams-Medina E; Bobbitt JR; Seachrist DD; Anstine LJ; Keri RA
J Biol Chem; 2021 Oct; 297(4):101162. PubMed ID: 34481843
[TBL] [Abstract][Full Text] [Related]
8. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells.
Thomas AL; Lind H; Hong A; Dokic D; Oppat K; Rosenthal E; Guo A; Thomas A; Hamden R; Jeruss JS
Cell Cycle; 2017 Aug; 16(15):1453-1464. PubMed ID: 28678584
[TBL] [Abstract][Full Text] [Related]
10. The testis protein ZNF165 is a SMAD3 cofactor that coordinates oncogenic TGFβ signaling in triple-negative breast cancer.
Gibbs ZA; Reza LC; Cheng CC; Westcott JM; McGlynn K; Whitehurst AW
Elife; 2020 Jun; 9():. PubMed ID: 32515734
[TBL] [Abstract][Full Text] [Related]
11. Phosphatase Cdc25A Negatively Regulates the Antiviral Immune Response by Inhibiting TBK1 Activity.
Qi D; Hu L; Jiao T; Zhang T; Tong X; Ye X
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021902
[TBL] [Abstract][Full Text] [Related]
12. Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression.
Parvani JG; Davuluri G; Wendt MK; Espinosa C; Tian M; Danielpour D; Sossey-Alaoui K; Schiemann WP
Neoplasia; 2015 Mar; 17(3):317-28. PubMed ID: 25810016
[TBL] [Abstract][Full Text] [Related]
13. Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways.
Sugiyama Y; Kakoi K; Kimura A; Takada I; Kashiwagi I; Wakabayashi Y; Morita R; Nomura M; Yoshimura A
Int Immunol; 2012 Apr; 24(4):253-65. PubMed ID: 22331441
[TBL] [Abstract][Full Text] [Related]
14. Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
Doherty MR; Cheon H; Junk DJ; Vinayak S; Varadan V; Telli ML; Ford JM; Stark GR; Jackson MW
Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13792-13797. PubMed ID: 29229854
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.
Vishnubalaji R; Alajez NM
Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372
[TBL] [Abstract][Full Text] [Related]
16. Smoking attenuates transforming growth factor-β-mediated tumor suppression function through downregulation of Smad3 in lung cancer.
Samanta D; Gonzalez AL; Nagathihalli N; Ye F; Carbone DP; Datta PK
Cancer Prev Res (Phila); 2012 Mar; 5(3):453-63. PubMed ID: 22232600
[TBL] [Abstract][Full Text] [Related]
17. Impaired mammary tumor formation and metastasis by the point mutation of a Smad3 linker phosphorylation site.
Huang CC; Huang MS; Chung HJ; Chiu SY; Yadav P; Lin Y; Liu F; Matsuura I
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3664-3671. PubMed ID: 30251686
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
Song K; Cornelius SC; Reiss M; Danielpour D
J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
[TBL] [Abstract][Full Text] [Related]
19. Protein phosphatase PP1 negatively regulates the Toll-like receptor- and RIG-I-like receptor-triggered production of type I interferon by inhibiting IRF3 phosphorylation at serines 396 and 385 in macrophage.
Gu M; Zhang T; lin W; Liu Z; Lai R; Xia D; Huang H; Wang X
Cell Signal; 2014 Dec; 26(12):2930-9. PubMed ID: 25239187
[TBL] [Abstract][Full Text] [Related]
20. Peste des Petits Ruminants Virus Nucleocapsid Protein Inhibits Beta Interferon Production by Interacting with IRF3 To Block Its Activation.
Zhu Z; Li P; Yang F; Cao W; Zhang X; Dang W; Ma X; Tian H; Zhang K; Zhang M; Xue Q; Liu X; Zheng H
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
